Specifications
| Item Number | 254933 |
|---|
| Administration Form | Oral |
|---|
| For Use With | Dogs |
|---|
| Common Brand Name(s) | Bravecto |
|---|
| Generic Name | Fluralaner |
|---|
| Usage | Prevention， Treatment |
|---|
| Repels or Prevents | Fleas |
|---|
| Kills or Treats | Fleas， Ticks |
|---|
| Lifestage | Puppy |
|---|
| Breed Size | Medium Breeds， Large Breeds， Small Breeds |
|---|
| Product Form | Chew |
|---|
| Strength | 45 mg fluralaner |
|---|
| Health Condition | Fleas， Ticks |
|---|
| Drug Type | Parasiticide |
|---|
Uses
Bravecto 1-Month kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of tick infestations (black-legged tick， American dog tick， and brown dog tick) for one month in dogs and puppies 8 weeks of age and older， and weighing 4.4 pounds or greater. Bravecto 1-Month is also indicated for the treatment and control of lone star tick infestations for one month in dogs and puppies 6 months of age and older， and weighing 4.4 pounds or greater.
Possible Side Effects
The most commonly reported adverse reactions include itching， diarrhea， vomiting， decreased appetite， elevated ALT， lethargy， and weight loss.
Drug & Food Interactions
Due to reduced drug bioavailability in the fasted state， fluralaner should be administered with food.
Precautions
Side effects may include itching， diarrhea， vomiting， decreased appetite， elevated ALT， lethargy， and weight loss. Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors， ataxia， and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs， even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. BRAVECTO 1-MONTH Chews are not effective against Lone Star ticks in puppies less than 6 months of age.
Comment